ClinConnect ClinConnect Logo
Search / Trial NCT06011941

Modified Laparoscopic Transcystic Biliary Drainage in the Management of Cholecystocholedocholithiasis

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Aug 22, 2023

Trial Information

Current as of July 12, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new method for treating patients with gallbladder stones and bile duct stones, a condition known as cholecystocholedocholithiasis. The researchers have developed a modified technique using a special catheter that aims to make it easier and safer to drain bile from the bile duct. This method not only helps with immediate treatment but also allows for easier follow-up care if any stones are left behind after surgery.

To participate in this study, you need to be at least 18 years old and have gallbladder stones along with possible bile duct stones. However, people who already have a drainage system in place, are pregnant, or have certain health concerns may not be eligible. If you choose to join the trial, you can expect to receive care using this new technique, which could potentially lead to better outcomes for managing your condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥ 18 years of age;
  • Patients with gallbladder stones and known or expected concomitant bile duct stones;
  • Informed consent.
  • Exclusion Criteria:
  • Biliary drainage is already present, e.g. preoperative ENBD, PTCD;
  • Women who are pregnant;
  • Declined consent;
  • Inability to follow the procedures of the study, e.g. due to language problems and psychological disorders of the participant;
  • Morbid obesity (BMI \> 40);
  • IV-VI class of the American Society of Anesthesiologists physical status classification;
  • Contraindications for general anesthesia or surgery.

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, None Selected, China

Patients applied

0 patients applied

Trial Officials

LINGFU ZHANG

Study Chair

北京大学第三医院

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported